Public Commentary: Patient-Reported Outcomes Measures Oncology
Patient-Reported Outcome Measures for Oncology Care (PROMOnc)
The Call for Public Comment period closed on January 29, 2020.
The Centers for Medicare & Medicaid Services (CMS) has awarded a Cooperative Agreement to the PBGH to develop and test patient-reported outcome-performance measures (PRO-PMs) for oncology care. The Cooperative Agreement’s goal is to develop and expand quality measures for use in the Quality Payment Program. The Cooperative Agreement grant program is MACRA/Measure Development for the Quality Payment Program, and the grant number is 1V1CMS331641. As part of its measure development process, PBGH requested interested parties to submit comments on the candidate or concept measures that may be suitable for this project.
The aims for this project are to enhance patient-centered cancer quality measurement by 1) fully developing and testing patient-reported outcome-performance measures (PRO-PMs) regarding health-related quality of life (HRQOL) and pain for patients with breast, colon and lung cancer, and 2) preparing documentation for successful submission of the measures to National Quality Forum (NQF) and CMS. We are testing two HRQOL measures and two pain measures and our objective is to develop at least one PRO-PM in each domain for submission to CMS and NQF.
The document, including a summary of public comments and responses, is viewable via link below:
PROMOnc Public Comment Summary Report
This notice expires on September 13, 2021.